A detailed history of Royal London Asset Management LTD transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Royal London Asset Management LTD holds 934,021 shares of A stock, worth $117 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
934,021
Previous 1,037,209 9.95%
Holding current value
$117 Million
Previous $144 Million 5.75%
% of portfolio
0.35%
Previous 0.42%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$128.12 - $149.31 $13.2 Million - $15.4 Million
-103,188 Reduced 9.95%
934,021 $136 Million
Q4 2023

Feb 13, 2024

SELL
$101.17 - $139.82 $24.7 Million - $34.2 Million
-244,337 Reduced 19.07%
1,037,209 $144 Million
Q3 2023

Nov 14, 2023

SELL
$109.73 - $128.47 $2.58 Million - $3.02 Million
-23,502 Reduced 1.8%
1,281,546 $143 Million
Q2 2023

Aug 11, 2023

BUY
$114.69 - $141.28 $770,831 - $949,542
6,721 Added 0.52%
1,305,048 $157 Million
Q1 2023

May 15, 2023

SELL
$131.13 - $159.06 $54.2 Million - $65.7 Million
-413,197 Reduced 24.14%
1,298,327 $180 Million
Q4 2022

Feb 09, 2023

SELL
$125.64 - $157.68 $22.7 Million - $28.5 Million
-180,464 Reduced 9.54%
1,711,524 $256 Million
Q3 2022

Nov 14, 2022

SELL
$115.11 - $142.29 $11.3 Million - $13.9 Million
-97,917 Reduced 4.92%
1,891,988 $230 Million
Q2 2022

Aug 12, 2022

BUY
$112.71 - $135.93 $1.71 Million - $2.07 Million
15,207 Added 0.77%
1,989,905 $236 Million
Q1 2022

May 13, 2022

BUY
$126.0 - $156.48 $8.36 Million - $10.4 Million
66,334 Added 3.48%
1,974,698 $261 Million
Q4 2021

Oct 18, 2022

BUY
$147.95 - $164.3 $6.38 Million - $7.09 Million
43,155 Added 2.31%
1,908,364 $305 Million
Q4 2021

Jan 18, 2022

BUY
$147.95 - $164.3 $6.38 Million - $7.09 Million
43,155 Added 2.31%
1,908,364 $305 Million
Q3 2021

Oct 18, 2022

SELL
$147.58 - $179.28 $5.67 Million - $6.89 Million
-38,427 Reduced 2.02%
1,865,209 $294 Million
Q3 2021

Nov 02, 2021

SELL
$147.58 - $179.28 $5.67 Million - $6.89 Million
-38,427 Reduced 2.02%
1,865,209 $294 Million
Q2 2021

Oct 18, 2022

SELL
$127.69 - $148.81 $11 Million - $12.8 Million
-86,269 Reduced 4.34%
1,903,636 $281 Million
Q2 2021

Jul 14, 2021

SELL
$127.69 - $148.81 $839,689 - $978,574
-6,576 Reduced 0.34%
1,903,636 $281 Million
Q1 2021

Oct 17, 2022

SELL
$114.99 - $130.12 $9.16 Million - $10.4 Million
-79,693 Reduced 4.0%
1,910,212 $243 Million
Q1 2021

Apr 13, 2021

BUY
$114.99 - $130.12 $815,969 - $923,331
7,096 Added 0.37%
1,910,212 $243 Million
Q4 2020

Jan 29, 2021

SELL
$100.01 - $119.3 $3.87 Million - $4.62 Million
-38,738 Reduced 1.99%
1,903,116 $225 Million
Q3 2020

Nov 04, 2020

BUY
$88.11 - $103.42 $32.4 Million - $38 Million
367,447 Added 23.34%
1,941,854 $195 Million
Q2 2020

Jul 31, 2020

BUY
$68.92 - $91.14 $9.54 Million - $12.6 Million
138,465 Added 9.64%
1,574,407 $137 Million
Q1 2020

May 01, 2020

BUY
$63.37 - $90.13 $6.29 Million - $8.94 Million
99,219 Added 7.42%
1,435,942 $104 Million
Q4 2019

Feb 05, 2020

BUY
$72.49 - $85.45 $8.27 Million - $9.74 Million
114,025 Added 9.33%
1,336,723 $114 Million
Q3 2019

Nov 12, 2019

BUY
$65.59 - $78.07 $28 Million - $33.3 Million
426,619 Added 53.59%
1,222,698 $93.7 Million
Q2 2019

Jul 31, 2019

BUY
$66.89 - $81.94 $3.76 Million - $4.61 Million
56,237 Added 7.6%
796,079 $59.4 Million
Q1 2019

Apr 30, 2019

BUY
$63.27 - $82.0 $24.2 Million - $31.4 Million
382,902 Added 107.27%
739,842 $0
Q4 2018

Jan 29, 2019

BUY
$61.13 - $74.67 $6.86 Million - $8.38 Million
112,256 Added 45.88%
356,940 $23.5 Million
Q3 2018

Nov 08, 2018

BUY
$61.25 - $71.13 $377,300 - $438,160
6,160 Added 2.58%
244,684 $0
Q2 2018

Sep 19, 2018

BUY
$61.14 - $69.55 $14.6 Million - $16.6 Million
238,524 New
238,524 $14.8 Million

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $37.2B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.